For research use only. Not for therapeutic Use.
HCV Peptide (35-44)(Cat No.:I042257)refers to a specific peptide fragment derived from the Hepatitis C virus (HCV) core protein, spanning amino acids 35 to 44. This peptide plays a role in the virus’s ability to evade the host immune system and facilitate infection. It has been studied for its potential in vaccine development and immune response modulation. Researchers are investigating the immunogenic properties of this peptide to help design therapies that enhance the body’s immune defense against HCV. Its use in therapeutic applications aims to develop more effective treatments for Hepatitis C.
Catalog Number | I042257 |
CAS Number | 160214-01-7 |
Molecular Formula | C57H97N19O12 |
Purity | ≥95% |
IUPAC Name | (2S)-2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid |
InChI | InChI=1S/C57H97N19O12/c1-31(2)26-40(72-46(79)36(58)29-34-17-19-35(77)20-18-34)50(83)73-41(27-32(3)4)53(86)76-25-11-16-44(76)52(85)71-38(13-8-22-66-56(61)62)48(81)69-37(12-7-21-65-55(59)60)47(80)68-30-45(78)75-24-10-15-43(75)51(84)70-39(14-9-23-67-57(63)64)49(82)74-42(54(87)88)28-33(5)6/h17-20,31-33,36-44,77H,7-16,21-30,58H2,1-6H3,(H,68,80)(H,69,81)(H,70,84)(H,71,85)(H,72,79)(H,73,83)(H,74,82)(H,87,88)(H4,59,60,65)(H4,61,62,66)(H4,63,64,67)/t36-,37-,38-,39-,40-,41-,42-,43-,44-/m0/s1 |
InChIKey | JIBVGDVCGOAYSP-FSLKYBNLSA-N |
SMILES | CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N |